SCHEMBL20073700

SCHEMBL20073700

CCOC(=O)NCC1CCN(C2CCC(NC)(c3ccccc3)CC2)CC1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
OPRM1 P35372 3/20 0.42
OPRD1 P41143 3/20 0.42
OPRK1 P41145 3/20 0.42
OPRL1 P41146 3/20 0.42
LMNA P02545 2/20 0.41
KDM4E B2RXH2 2/20 0.41
ACACB O00763 1/20 0.41
ACACA Q13085 1/20 0.41
POLB P06746 2/20 0.40
PKM P14618 1/20 0.40
MAPT P10636 1/20 0.40
KMT2A Q03164 3/20 0.39
ALDH1A1 P00352 1/20 0.39
KCNH2 Q12809 3/20 0.39
TACR1 P25103 3/20 0.39
BCHE P06276 1/20 0.39
SLC22A1 O15245 1/20 0.38
SLC6A4 P31645 1/20 0.38
ADRA1A P35348 1/20 0.38
MEN1 O00255 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20066070 0.84 CYP2D6 (0.46) OPRM1OPRD1OPRK1OPRL1LMNA
SCHEMBL24609048 0.80 MEN1 (0.49) LMNAKDM4EPOLBKMT2AALDH1A1
SCHEMBL23778367 0.79 CYP2D6 (0.52) OPRM1OPRD1OPRK1OPRL1LMNA
SCHEMBL23778311 0.79 CYP2D6 (0.52) OPRM1OPRD1OPRK1OPRL1LMNA
SCHEMBL20073973 0.78 POLB (0.48) LMNAKDM4EPOLBMAPTKMT2A
SCHEMBL20066072 0.77 OPRM1 (0.44) OPRM1OPRD1OPRK1OPRL1KDM4E
SCHEMBL29709409 0.77 OPRM1 (0.44) OPRM1OPRD1OPRK1OPRL1KDM4E
SCHEMBL20073800 0.76 PDE10A (0.39) OPRM1OPRL1LMNAPOLBPKM
SCHEMBL20073809 0.76 PDE10A (0.39) OPRM1OPRL1LMNAPOLBPKM
SCHEMBL4562996 0.73 OPRL1 (0.60) OPRM1OPRK1OPRL1KDM4EKCNH2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2018069732-A1 HETEROCYCLIC COMPOUNDS HAVING ACTIVITY AS MODULATORS OF MUSCARINIC M1 AND/OR M4 RECEPTORS IN THE TREATMENT OF CNS DISEASES AND PAINS. HEPTARES THERAPEUTICS LIMITED (GB) 2018-04-19 WO disclosed